EP2101569
Kristallaður rasigilín basi á föstu formi.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
13.12.2007EP published:
19.10.2011EP application number:
07862906.0
EP translation filed:
29.12.2011Grant published:
15.1.2012EPO information:
European Patent Register
Max expiry date:
12.12.2027Expiry date:
12.12.2017
Title:
CRYSTALLINE SOLID RASAGILINE BASE
Timeline
Today
13.12.2007EP application
19.10.2011EP Publication
29.12.2011Translation submitted
15.1.2012Registration published
12.12.2017Expires
Owner
Name:
Teva Pharmaceutical Industries, Ltd.Address:
5 Basel Street P.O. Box 3190, 49131, Petach-Tikva, IL
Inventor
Name:
FRENKEL, AntonAddress:
Netanya, IL
Name:
KOLTAI, TamasAddress:
Netanya, IL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
875011 PDate:
14.12.2006Country:
US
Classification
Categories:
A01N 33/02, A61K 31/135
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 22.12.2011
Expires: 12.12.2012
Payer: G. H. Sigurgeirsson
Number: 6
Paid: 20.11.2012
Expires: 12.12.2013
Payer: G. H. Sigurgeirsson
Number: 7
Paid: 20.11.2013
Expires: 12.12.2014
Payer: G. H. Sigurgeirsson
Number: 8
Paid: 11.11.2014
Expires: 12.12.2015
Payer: G. H. Sigurgeirsson
Number: 9
Paid: 18.11.2015
Expires: 12.12.2016
Payer: G. H. Sigurgeirsson
Number: 10
Paid: 21.11.2016
Expires: 12.12.2017
Payer: G. H. Sigurgeirsson